Products Home

China 's medicine industry in the first quarter of 2006, the first year of Eleventh Five Year Plan, maintains a good momentum of growth in the production and distribution. With a better situation of export, the medicine production and export keeps on a rapid growth.

The medicine industry reaches a total production value of 113.4 billion RMB, with an increase of 20.7%. Among the growth, the total production value of Chemical raw material medicine and biological and biochemical pharmaceutical reaches 27.8 and 8.68 billion RMB separately.

The medicine industry has completed an export delivery of 13.8 billion RMB, with an increase of 29.5%, and the amplitude of increase raises 9.7%.

With export of China's medicine keeps high speed growth, Kelun Bio-Pharma provide to its overseas customers the quality-assuranced and finest products, especially genetic and blood related products.

Please search the Products Profile for products details or download the full products list (Trade Leads) from Products Overall List .

Please contact us for Catalogue 2006 if you’d like to know more information about Kelun’ Products.

 

 


White Paper
Status Quo of Drug Supervision in China

·

China suspends blood-drug after users test postive for hepatitic C antibodies
China has suspended the production and sale of a drug, which is an extract of human blood, after people being treated with it tested positive for hepatitis C antibodies, announced officials with the Ministry of Health (MOH) and the State Food and Drug Administration (SFDA).

·

Kelun's CPhI 2007
CPhI 2007 Shanghai is a place for pharmaceutical professionals.


Copyright & Legal Disclaimer | Privacy Policy                         © Kelun Bio-Pharma